IN2014DE00818AIN818DE2014AIN2014DE00818AIN 2014DE00818 AIN2014DE00818 AIN 2014DE00818AIN 818DE2014 AIN818DE2014 AIN 818DE2014AIN 2014DE00818 AIN2014DE00818 AIN 2014DE00818A
Authority
IN
India
Prior art keywords
subject
diabetes
borapetoside
metabolite
prodrug
Prior art date
Application number
Inventor
Ming-Jai Su
Shoei-Sheng Lee
Original Assignee
Orient Europharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orient Europharma Co LtdfiledCriticalOrient Europharma Co Ltd
Priority to IN818DE2014priorityCriticalpatent/IN2014DE00818A/en
Publication of IN2014DE00818ApublicationCriticalpatent/IN2014DE00818A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present invention is directed to therapeutic methods and compositions for treating insulin resistant diabetes or diabetes with inflammation in a subject comprising administering an effective amount of borapetoside A, or a pharmaceutically acceptable salt, metabolite, solvate or prodrug thereof, to said subject.
An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes